Sign Up to like & get recommendations! 0
Published in 2017 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2017.2952
Abstract: Importance For patients with asymptomatic severe aortic stenosis and normal left ventricular function, current practice guidelines empirically recommend serial evaluations every 6 to 12 months. The benefit of this clinical monitoring is unknown. Objective To… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.5916
Abstract: Importance Recent studies have questioned the presumed low-risk status of patients with asymptomatic nonsevere aortic stenosis (AS). Whether annual N-terminal pro-brain natriuretic peptide (NT-proBNP) measurements are useful for risk assessment is unknown. Objective To assess… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27257
Abstract: Racial disparities in cardiovascular care have been extensively investigated. The introduction of transcatheter aortic valve replacement (TAVR) revolutionized the treatment of aortic stenosis (AS) in the last decade. Whether a racial disparity in the utilization… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28226
Abstract: This study reports the 1‐year clinical outcomes of the VitaFlow™ transcatheter aortic valve system in the treatment of severe aortic stenosis. read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29227
Abstract: To evaluate the incidence, predictors and outcomes of female patients with patient‐prosthesis mismatch (PPM) following transcatheter aortic valve intervention (TAVI) for severe aortic stenosis (AS). read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30374
Abstract: “Optima dies ... prima fugit.” “The best days are the first to flee.” – Georgics, Book III, Virgil As lifespans increase and populations age in developed countries, the cohort of patients presenting for medical care… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30413
Abstract: Before the development of transcatheter aortic valve replacement (TAVR), balloon aortic valvuloplasty (BAV) was the only potential nonsurgical intervention for patients with aortic stenosis complicated by cardiogenic shock. Emergent TAVR is now an option and… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30486
Abstract: Rapid advances in transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) and edge‐to‐edge repair for mitral regurgitation have expanded the nonsurgical armamentarium for valvular heart disease complicated by profound hemodynamic compromise. The present study… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22775
Abstract: Subvalvular aortic stenosis (SAS) is one of the common adult congenital heart diseases, with a prevalence of 6.5%. It is usually diagnosed in the first decade of life. Echocardiography is the test of choice to… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical Cardiology"
DOI: 10.1002/clc.23138
Abstract: We aimed to assess longitudinal changes of B‐type natriuretic peptide (BNP) in aortic stenosis (AS) patients treated by transcatheter aortic valve replacement (TAVR). read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical Cardiology"
DOI: 10.1002/clc.23685
Abstract: The new 2018 pulmonary hypertension (PH) definition includes a lower mean pulmonary artery pressure (mPAP) cut‐off (>20 mmHg rather than ≥25 mmHg) and the compulsory requirement of a pulmonary vascular resistance (PVR) ≥3 Wood units (WU) to… read more here.